ARAY : Summary for Accuray Incorporated - Yahoo Finance

U.S. Markets open in 2 hrs 12 mins

Accuray Incorporated (ARAY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.45+0.02 (+0.46%)
At close: 4:00PM EST
People also watch
HNSNANGOABMDVARATEC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.43
Open5.40
Bid4.95 x 100
Ask5.70 x 100
Day's Range5.35 - 5.45
52 Week Range4.45 - 6.39
Volume439,342
Avg. Volume663,778
Market Cap451.79M
Beta2.15
PE Ratio (TTM)-17.08
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire6 days ago

    Accuray to Present at Cowen and Company 37th Annual Healthcare Conference on March 6, 2017

    SUNNYVALE, Calif., Feb. 21, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that the Company will present at Cowen and Company's 37 th Annual Healthcare Conference in Boston on ...

  • PR Newswire11 days ago

    CyberKnife® System Provides Long-term Disease Control for Prostate Cancer Patients

    SUNNYVALE, Calif., Feb. 16, 2017 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today data from a prospective, Phase II, 17-center study which showed that treatment with the CyberKnife® System for low- and intermediate-risk prostate cancer provides excellent long-term results.  At five years, the disease-free survival rate for low-risk prostate cancer patients was 100 percent and for intermediate-risk patients was 88.5 percent. A low prostate specific antigen (PSA) value is associated with a reduced risk of cancer recurrence or metastases. According to the study, the five-year median PSA was 0.1 ng/mL for low- and intermediate-risk prostate cancer patients receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife System.

  • Better Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated
    Motley Fool14 days ago

    Better Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated

    Making surgical robots is an exciting business, but only one is investment-worthy right now.